Xavier Vidal

6.8k total citations · 2 hit papers
123 papers, 4.9k citations indexed

About

Xavier Vidal is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Geriatrics and Gerontology. According to data from OpenAlex, Xavier Vidal has authored 123 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 20 papers in Pharmacology and 17 papers in Geriatrics and Gerontology. Recurrent topics in Xavier Vidal's work include Pharmaceutical Practices and Patient Outcomes (16 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Drug-Induced Hepatotoxicity and Protection (8 papers). Xavier Vidal is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (16 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Drug-Induced Hepatotoxicity and Protection (8 papers). Xavier Vidal collaborates with scholars based in Spain, Palestinian Territory and Italy. Xavier Vidal's co-authors include Joan‐Ramon Laporte, Luisa Ibáñez, Elena Ballarín, Lourdes Vendrell, Dolors Capellà, Miguel Casas, Xavier Castells, Antònia Agustí, Vı́ctor Moreno and Xavier Carné and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Xavier Vidal

117 papers receiving 4.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease

2014 429 citations Israel Molina, Jordi Gómez i Prat et al. New England Journal of Medicine profile →
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome

2019 204 citations Josep Ordi‐Ros, Luís Sáez-Comet et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Xavier Vidal	1.3k	813	655	631	604	123	4.9k
Tsai‐Chung Li	1.2k 0.9×	530 0.7×	675 1.0×	713 1.1×	177 0.3×	325	7.2k
Dario Cattaneo	810 0.6×	714 0.9×	498 0.8×	1.1k 1.7×	394 0.7×	233	5.8k
Edeltraut Garbe	1.1k 0.9×	881 1.1×	617 0.9×	804 1.3×	89 0.1×	174	6.9k
Kim McFann	770 0.6×	328 0.4×	366 0.6×	1.3k 2.0×	144 0.2×	121	7.6k
Mary H. H. Ensom	718 0.6×	866 1.1×	593 0.9×	705 1.1×	145 0.2×	194	5.4k
Eli A. Friedman	944 0.7×	194 0.2×	639 1.0×	1.3k 2.1×	411 0.7×	292	8.9k
Patrick Blin	580 0.5×	408 0.5×	249 0.4×	392 0.6×	205 0.3×	152	3.4k
Dean T. Eurich	2.0k 1.6×	423 0.5×	482 0.7×	1.0k 1.6×	139 0.2×	284	8.0k
Susan E. Tett	523 0.4×	595 0.7×	394 0.6×	948 1.5×	265 0.4×	119	5.4k
Francisco J. de Abajo	848 0.7×	804 1.0×	182 0.3×	491 0.8×	93 0.2×	130	3.8k

Countries citing papers authored by Xavier Vidal

Since Specialization

Citations

This map shows the geographic impact of Xavier Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Vidal more than expected).

Fields of papers citing papers by Xavier Vidal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Vidal. The network helps show where Xavier Vidal may publish in the future.

Co-authorship network of co-authors of Xavier Vidal

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Vidal. A scholar is included among the top collaborators of Xavier Vidal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Vidal. Xavier Vidal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Camacho-Arteaga, Lina, Gloria Iacoboni, Mi Kwon, et al.. (2025). Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma. JAMA Network Open. 8(2). e2461683–e2461683.

Oscanoa, Teodoro J., et al.. (2023). Evaluation of the Timed Up and Go test for screening vulnerability and frailty in older cancer patients. Oncology in Clinical Practice. 20(1). 9–14. 1 indexed citations

Mallah, Narmeen, Maruxa Zapata‐Cachafeiro, C Aguirre, et al.. (2022). Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study. Annals of Medicine. 54(1). 379–392. 4 indexed citations

Agustí, Antònia, Andrés Antón, Cristina Aguilera, et al.. (2020). Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial. Enfermedades Infecciosas y Microbiología Clínica. 40(6). 289–295. 5 indexed citations

Mallah, Narmeen, Maruxa Zapata‐Cachafeiro, C Aguirre, et al.. (2020). Influence of Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control Study. Frontiers in Pharmacology. 11. 1072–1072. 17 indexed citations

Gómez-Lumbreras, Ainhoa, Elena Ballarín, Mònica Sabaté, et al.. (2019). Study of antidepressant use in 5 European settings. Could economic, sociodemographic and cultural determinants be related to their use?. Journal of Affective Disorders. 249. 278–285. 28 indexed citations

Vidal, Xavier, et al.. (2018). Efficacy of radial extracorporeal shock wave therapy compared to botulinum toxin type a in the treatment of lower extremity spasticity in patients with cerebral palsy. Annals of Physical and Rehabilitation Medicine. 61. e58–e58.

Ordi‐Ros, Josep, Luís Sáez-Comet, Mercedes Pérez-Conesa, et al.. (2017). Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial. Annals of the Rheumatic Diseases. 76(9). 1575–1582. 56 indexed citations

Formiga, Françesc, Xavier Vidal, Antònia Agustí, et al.. (2015). Inappropriate prescribing in elderly people with diabetes admitted to hospital. Diabetic Medicine. 33(5). 655–662. 36 indexed citations

10.

Molina, Israel, Jordi Gómez i Prat, Fernando Salvador, et al.. (2014). Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease. New England Journal of Medicine. 370(20). 1899–1908. 429 indexed citations breakdown →

11.

Machado‐Alba, Jorge Enrique & Xavier Vidal. (2013). Evaluación de la respuesta y seguridad a diferentes esquemas de tratamiento antirretroviral en Colombia. 15(27). 770–783. 2 indexed citations

12.

Pérez, E., Sergio Abanades, Xavier Vidal, et al.. (2010). Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting. British Journal of Clinical Pharmacology. 70(5). 656–663. 105 indexed citations

13.

Montané, Eva, Luisa Ibáñez, Xavier Vidal, et al.. (2008). Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica. 93(4). 518–523. 126 indexed citations

14.

Pellisé, Ferrán, et al.. (2007). Radiologic Assessment of All Unfused Lumbar Segments 7.5 Years After Instrumented Posterior Spinal Fusion. Spine. 32(5). 574–579. 72 indexed citations

15.

Montané, Eva, et al.. (2006). Analgesics for pain after traumatic or orthopaedic surgery: what is the evidence-a systematic review. European Journal of Clinical Pharmacology. 62(11). 971–988. 8 indexed citations

16.

Vidal, Xavier, et al.. (2005). Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease. Kidney International. 67(6). 2393–2398. 28 indexed citations

17.

Ibáñez, Luisa, et al.. (2005). Upper gastrointestinal bleeding associated with antiplatelet drugs. Alimentary Pharmacology & Therapeutics. 23(2). 235–242. 101 indexed citations

18.

Bonet, Sergi, Antònia Agustí, Josep Arnau, et al.. (2000). β-Adrenergic Blocking Agents in Heart Failure. Archives of Internal Medicine. 160(5). 621–7. 68 indexed citations

19.

Ferrer, Jaume, et al.. (1994). Energy-Dispersive X-Ray Analysis and Scanning Electron Microscopy of Pleura. Study of Reference, Exposed Non-Pneumoconiotic, and Silicotic Populations. American Journal of Respiratory and Critical Care Medicine. 149(4). 888–892. 12 indexed citations

20.

Rodríguez, Charo, et al.. (1989). [Therapeutic consultation: information oriented to clinical problems].. PubMed. 185(8). 409–14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact